Marshall Wace, LLP Avita Medical, Inc. Transaction History
Marshall Wace, LLP
- $90.8 Billion
- Q3 2025
A detailed history of Marshall Wace, LLP transactions in Avita Medical, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 42,807 shares of RCEL stock, worth $160,526. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,807
Previous 76,825
44.28%
Holding current value
$160,526
Previous $406,000
46.55%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding RCEL
# of Institutions
81Shares Held
5.81MCall Options Held
77.4KPut Options Held
19.4K-
Black Rock Inc. New York, NY1.78MShares$6.69 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.37MShares$5.12 Million0.0% of portfolio
-
State Street Corp Boston, MA423KShares$1.59 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA331KShares$1.24 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL173KShares$647,9170.0% of portfolio
About AVITA Medical, Inc.
- Ticker RCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 25,030,900
- Market Cap $93.9M
- Description
- AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...